FIELD: medicine.
SUBSTANCE: invention represents an ophthalmic composition of eye drops for treating antibiotic-resistant infectious-inflammatory eye disease consists of an antiseptic specified in a group of: polyhexanide biguanide, chlorhexidine, boric acid, and dexpathenol; as a consistence-forming base, it contains an ingredient specified in a group of: macrogol 400, macrogol 4000, carbopol, polyvinyl pirrolidone, polyethylene glycol, dextrane and hypromellose with the ingredients of the composition taken in certain ratio, wt %.
EFFECT: effective treatment of the antibiotic-resistant infectious eye diseases.
4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| OPHTHALMIC COMPOSITION OF EYE DROPS FOR TREATING ANTIBIOTIC-RESISTANT INFECTIOUS-INFLAMMATORY EYE DISEASES | 2014 |
|
RU2561049C1 |
| PHARMACEUTICAL COMPOSITION IN FORM OF EYE DROPS FOR PREVENTING AND TREATING ALLERGIC EYE DISEASES | 2013 |
|
RU2549472C1 |
| GEL DROPS FOR TREATING INFLAMMATORY EYE DISEASES, INCLUDING INFECTIOUS AND SUSTAINABLE TO ANTIBIOTICS DISEASES | 2017 |
|
RU2669768C1 |
| PHARMACEUTICAL COMPOSITION IN FORM OF GEL FOR TREATING METABOLIC INVOLVEMENTS OF OCULAR TISSUES | 2014 |
|
RU2575558C1 |
| EYE DROPS | 2012 |
|
RU2504372C1 |
| GEL-LIKE EYE DROPS FOR TREATMENT OF INFLAMMATORY ALLERGIC, BACTERIAL, VIRAL, TRAUMATIC AND DYSTROPHIC EYE DISEASES | 2014 |
|
RU2561046C1 |
| OPHTHALMIC GEL COMPOSITION FOR TREATING CONJUNCTIVITIS, BLEPHARITIS, KERATITIS CORNEAL EROSION ASSOCIATED WITH INFLAMMATORY EYE DISEASES OF NON-INFECTIOUS OR POST-INFECTIOUS ETIOLOGY AND ALLERGIC LESIONS OF OCULAR SURFACE | 2014 |
|
RU2582284C1 |
| OPHTHALMIC COMPOSITION FOR TREATMENT OF CONJUNCTIVITES, BLEPARITIS AND MARGINAL CORNEAL ULCERS IN TOPICAL APPLICATION | 2016 |
|
RU2633055C1 |
| EYE DROPS POSSESSING ANTIINFLAMMATORY AND ANTIBACTERIAL ACTION | 2012 |
|
RU2506086C1 |
| EYE DROPS FOR DRY EYE SYNDROME | 2011 |
|
RU2459615C1 |
